nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC3—Rifampicin—leprosy	0.359	0.451	CbGbCtD
Lamivudine—ABCC1—Rifampicin—leprosy	0.22	0.277	CbGbCtD
Lamivudine—ABCC2—Rifampicin—leprosy	0.163	0.205	CbGbCtD
Lamivudine—ABCB1—Rifampicin—leprosy	0.0532	0.0668	CbGbCtD
Lamivudine—NME1—Mafenide—Dapsone—leprosy	0.00609	0.822	CbGdCrCtD
Lamivudine—NME1-NME2—eye—leprosy	0.00528	0.0727	CbGeAlD
Lamivudine—PGK1—skin of body—leprosy	0.00504	0.0695	CbGeAlD
Lamivudine—NT5C—eye—leprosy	0.00489	0.0674	CbGeAlD
Lamivudine—Suicide attempt—Dapsone—leprosy	0.00473	0.038	CcSEcCtD
Lamivudine—Autoimmune disorder—Thalidomide—leprosy	0.00412	0.033	CcSEcCtD
Lamivudine—PCYT2—testis—leprosy	0.0037	0.051	CbGeAlD
Lamivudine—PCYT2—nervous system—leprosy	0.00363	0.05	CbGeAlD
Lamivudine—Fungal skin infection—Thalidomide—leprosy	0.00329	0.0264	CcSEcCtD
Lamivudine—NT5C—tendon—leprosy	0.00324	0.0447	CbGeAlD
Lamivudine—PGK1—testis—leprosy	0.00318	0.0438	CbGeAlD
Lamivudine—PGK1—nervous system—leprosy	0.00312	0.043	CbGeAlD
Lamivudine—Raised liver function tests—Thalidomide—leprosy	0.00298	0.0239	CcSEcCtD
Lamivudine—NME2—eye—leprosy	0.00289	0.0399	CbGeAlD
Lamivudine—NT5C—testis—leprosy	0.00268	0.037	CbGeAlD
Lamivudine—NME1—skin of body—leprosy	0.00267	0.0368	CbGeAlD
Lamivudine—NT5C—nervous system—leprosy	0.00263	0.0363	CbGeAlD
Lamivudine—CMPK1—skin of body—leprosy	0.00257	0.0355	CbGeAlD
Lamivudine—PCYT1A—testis—leprosy	0.00252	0.0347	CbGeAlD
Lamivudine—PCYT1A—nervous system—leprosy	0.00247	0.0341	CbGeAlD
Lamivudine—Suicide attempt—Thalidomide—leprosy	0.00242	0.0194	CcSEcCtD
Lamivudine—Hepatomegaly—Thalidomide—leprosy	0.00194	0.0156	CcSEcCtD
Lamivudine—Amblyopia—Thalidomide—leprosy	0.00178	0.0143	CcSEcCtD
Lamivudine—Hyperaesthesia—Thalidomide—leprosy	0.00175	0.014	CcSEcCtD
Lamivudine—Nasopharyngitis—Dapsone—leprosy	0.00174	0.014	CcSEcCtD
Lamivudine—Muscular weakness—Dapsone—leprosy	0.00172	0.0138	CcSEcCtD
Lamivudine—Influenza—Dapsone—leprosy	0.00168	0.0135	CcSEcCtD
Lamivudine—NME1—testis—leprosy	0.00168	0.0232	CbGeAlD
Lamivudine—NME1—nervous system—leprosy	0.00165	0.0228	CbGeAlD
Lamivudine—Pancreatitis—Dapsone—leprosy	0.00165	0.0132	CcSEcCtD
Lamivudine—Blood disorder—Thalidomide—leprosy	0.00165	0.0132	CcSEcCtD
Lamivudine—Acne—Thalidomide—leprosy	0.00163	0.0131	CcSEcCtD
Lamivudine—CMPK1—testis—leprosy	0.00162	0.0224	CbGeAlD
Lamivudine—CMPK1—nervous system—leprosy	0.00159	0.0219	CbGeAlD
Lamivudine—NME2—testis—leprosy	0.00159	0.0219	CbGeAlD
Lamivudine—Vasodilation—Thalidomide—leprosy	0.00156	0.0125	CcSEcCtD
Lamivudine—Vasodilation procedure—Thalidomide—leprosy	0.00156	0.0125	CcSEcCtD
Lamivudine—NME2—nervous system—leprosy	0.00156	0.0215	CbGeAlD
Lamivudine—Bone disorder—Thalidomide—leprosy	0.00152	0.0122	CcSEcCtD
Lamivudine—Viral infection—Thalidomide—leprosy	0.00152	0.0122	CcSEcCtD
Lamivudine—Drug interaction—Thalidomide—leprosy	0.00148	0.0119	CcSEcCtD
Lamivudine—Neuropathy peripheral—Dapsone—leprosy	0.00147	0.0118	CcSEcCtD
Lamivudine—Hypercholesterolaemia—Thalidomide—leprosy	0.00145	0.0117	CcSEcCtD
Lamivudine—Hearing impaired—Thalidomide—leprosy	0.00144	0.0116	CcSEcCtD
Lamivudine—Sinusitis—Dapsone—leprosy	0.00141	0.0113	CcSEcCtD
Lamivudine—Eructation—Thalidomide—leprosy	0.00135	0.0108	CcSEcCtD
Lamivudine—Pharyngitis—Dapsone—leprosy	0.00134	0.0107	CcSEcCtD
Lamivudine—DCK—Menadione—Thalidomide—leprosy	0.00132	0.178	CbGdCrCtD
Lamivudine—Neuropathy—Thalidomide—leprosy	0.00129	0.0104	CcSEcCtD
Lamivudine—Aplastic anaemia—Thalidomide—leprosy	0.00129	0.0104	CcSEcCtD
Lamivudine—Gynaecomastia—Thalidomide—leprosy	0.00123	0.00986	CcSEcCtD
Lamivudine—Sepsis—Thalidomide—leprosy	0.00119	0.00957	CcSEcCtD
Lamivudine—Erythema—Dapsone—leprosy	0.00117	0.00942	CcSEcCtD
Lamivudine—Lymphadenopathy—Thalidomide—leprosy	0.00117	0.00938	CcSEcCtD
Lamivudine—Gastroenteritis—Thalidomide—leprosy	0.00113	0.00903	CcSEcCtD
Lamivudine—Deafness—Thalidomide—leprosy	0.00111	0.00895	CcSEcCtD
Lamivudine—Injury—Thalidomide—leprosy	0.00109	0.00871	CcSEcCtD
Lamivudine—Vertigo—Dapsone—leprosy	0.00105	0.00846	CcSEcCtD
Lamivudine—Cough—Dapsone—leprosy	0.00102	0.00822	CcSEcCtD
Lamivudine—Hypoglycaemia—Thalidomide—leprosy	0.00102	0.0082	CcSEcCtD
Lamivudine—Migraine—Thalidomide—leprosy	0.000982	0.00788	CcSEcCtD
Lamivudine—Affect lability—Thalidomide—leprosy	0.000982	0.00788	CcSEcCtD
Lamivudine—DCK—tendon—leprosy	0.000975	0.0134	CbGeAlD
Lamivudine—Mood swings—Thalidomide—leprosy	0.000945	0.00758	CcSEcCtD
Lamivudine—Dehydration—Thalidomide—leprosy	0.000928	0.00744	CcSEcCtD
Lamivudine—Liver function test abnormal—Thalidomide—leprosy	0.000921	0.00739	CcSEcCtD
Lamivudine—Cramp muscle—Thalidomide—leprosy	0.000898	0.00721	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000898	0.00721	CcSEcCtD
Lamivudine—Muscular weakness—Thalidomide—leprosy	0.00088	0.00706	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Thalidomide—leprosy	0.00088	0.00706	CcSEcCtD
Lamivudine—Abdominal distension—Thalidomide—leprosy	0.000868	0.00696	CcSEcCtD
Lamivudine—Insomnia—Dapsone—leprosy	0.000866	0.00695	CcSEcCtD
Lamivudine—Dysphagia—Thalidomide—leprosy	0.000862	0.00692	CcSEcCtD
Lamivudine—Influenza—Thalidomide—leprosy	0.000862	0.00692	CcSEcCtD
Lamivudine—Pancreatitis—Thalidomide—leprosy	0.000845	0.00678	CcSEcCtD
Lamivudine—Bronchitis—Thalidomide—leprosy	0.000829	0.00665	CcSEcCtD
Lamivudine—Pancytopenia—Thalidomide—leprosy	0.000819	0.00657	CcSEcCtD
Lamivudine—DCK—testis—leprosy	0.000808	0.0111	CbGeAlD
Lamivudine—Neutropenia—Thalidomide—leprosy	0.000806	0.00647	CcSEcCtD
Lamivudine—Pollakiuria—Thalidomide—leprosy	0.000796	0.00639	CcSEcCtD
Lamivudine—DCK—nervous system—leprosy	0.000793	0.0109	CbGeAlD
Lamivudine—Gastrointestinal pain—Dapsone—leprosy	0.000783	0.00628	CcSEcCtD
Lamivudine—Hyperglycaemia—Thalidomide—leprosy	0.000778	0.00624	CcSEcCtD
Lamivudine—ABCC3—testis—leprosy	0.000773	0.0107	CbGeAlD
Lamivudine—ABCC4—tendon—leprosy	0.000771	0.0106	CbGeAlD
Lamivudine—Depression—Thalidomide—leprosy	0.000766	0.00615	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000762	0.00611	CcSEcCtD
Lamivudine—ABCB1—blood vessel—leprosy	0.000761	0.0105	CbGeAlD
Lamivudine—ABCC3—nervous system—leprosy	0.000759	0.0105	CbGeAlD
Lamivudine—Abdominal pain—Dapsone—leprosy	0.000757	0.00607	CcSEcCtD
Lamivudine—Body temperature increased—Dapsone—leprosy	0.000757	0.00607	CcSEcCtD
Lamivudine—Renal failure—Thalidomide—leprosy	0.000756	0.00606	CcSEcCtD
Lamivudine—Neuropathy peripheral—Thalidomide—leprosy	0.000753	0.00605	CcSEcCtD
Lamivudine—Stomatitis—Thalidomide—leprosy	0.000749	0.00601	CcSEcCtD
Lamivudine—ABCC2—tendon—leprosy	0.000746	0.0103	CbGeAlD
Lamivudine—Sweating—Thalidomide—leprosy	0.000737	0.00591	CcSEcCtD
Lamivudine—Epistaxis—Thalidomide—leprosy	0.000725	0.00582	CcSEcCtD
Lamivudine—Sinusitis—Thalidomide—leprosy	0.000721	0.00579	CcSEcCtD
Lamivudine—Agranulocytosis—Thalidomide—leprosy	0.000717	0.00576	CcSEcCtD
Lamivudine—Rhinitis—Thalidomide—leprosy	0.000692	0.00555	CcSEcCtD
Lamivudine—Hepatitis—Thalidomide—leprosy	0.00069	0.00554	CcSEcCtD
Lamivudine—Hypoaesthesia—Thalidomide—leprosy	0.000687	0.00551	CcSEcCtD
Lamivudine—Pharyngitis—Thalidomide—leprosy	0.000685	0.0055	CcSEcCtD
Lamivudine—SLC22A1—nervous system—leprosy	0.000676	0.00932	CbGeAlD
Lamivudine—SLC22A3—testis—leprosy	0.000658	0.00908	CbGeAlD
Lamivudine—ABCC1—tendon—leprosy	0.000657	0.00906	CbGeAlD
Lamivudine—Erythema multiforme—Thalidomide—leprosy	0.000652	0.00524	CcSEcCtD
Lamivudine—SLC22A3—nervous system—leprosy	0.000646	0.00891	CbGeAlD
Lamivudine—ABCC4—testis—leprosy	0.000638	0.0088	CbGeAlD
Lamivudine—ABCC4—nervous system—leprosy	0.000626	0.00864	CbGeAlD
Lamivudine—Immune system disorder—Thalidomide—leprosy	0.000623	0.005	CcSEcCtD
Lamivudine—Mediastinal disorder—Thalidomide—leprosy	0.000622	0.00499	CcSEcCtD
Lamivudine—Chills—Thalidomide—leprosy	0.000619	0.00497	CcSEcCtD
Lamivudine—ABCC2—testis—leprosy	0.000618	0.00852	CbGeAlD
Lamivudine—Alopecia—Thalidomide—leprosy	0.00061	0.00489	CcSEcCtD
Lamivudine—Vomiting—Dapsone—leprosy	0.000609	0.00489	CcSEcCtD
Lamivudine—Malnutrition—Thalidomide—leprosy	0.000601	0.00482	CcSEcCtD
Lamivudine—Headache—Dapsone—leprosy	0.0006	0.00481	CcSEcCtD
Lamivudine—Flatulence—Thalidomide—leprosy	0.000592	0.00475	CcSEcCtD
Lamivudine—Tension—Thalidomide—leprosy	0.000589	0.00473	CcSEcCtD
Lamivudine—Dysgeusia—Thalidomide—leprosy	0.000588	0.00472	CcSEcCtD
Lamivudine—Nervousness—Thalidomide—leprosy	0.000583	0.00468	CcSEcCtD
Lamivudine—Back pain—Thalidomide—leprosy	0.000581	0.00466	CcSEcCtD
Lamivudine—Muscle spasms—Thalidomide—leprosy	0.000578	0.00463	CcSEcCtD
Lamivudine—Nausea—Dapsone—leprosy	0.000569	0.00456	CcSEcCtD
Lamivudine—Tremor—Thalidomide—leprosy	0.000563	0.00452	CcSEcCtD
Lamivudine—Ill-defined disorder—Thalidomide—leprosy	0.000557	0.00447	CcSEcCtD
Lamivudine—Anaemia—Thalidomide—leprosy	0.000555	0.00445	CcSEcCtD
Lamivudine—Angioedema—Thalidomide—leprosy	0.000549	0.0044	CcSEcCtD
Lamivudine—ABCC1—testis—leprosy	0.000544	0.0075	CbGeAlD
Lamivudine—Malaise—Thalidomide—leprosy	0.000542	0.00435	CcSEcCtD
Lamivudine—Vertigo—Thalidomide—leprosy	0.00054	0.00433	CcSEcCtD
Lamivudine—Syncope—Thalidomide—leprosy	0.000539	0.00432	CcSEcCtD
Lamivudine—Leukopenia—Thalidomide—leprosy	0.000538	0.00431	CcSEcCtD
Lamivudine—Loss of consciousness—Thalidomide—leprosy	0.000528	0.00424	CcSEcCtD
Lamivudine—Cough—Thalidomide—leprosy	0.000524	0.00421	CcSEcCtD
Lamivudine—Convulsion—Thalidomide—leprosy	0.00052	0.00418	CcSEcCtD
Lamivudine—Arthralgia—Thalidomide—leprosy	0.000511	0.0041	CcSEcCtD
Lamivudine—Myalgia—Thalidomide—leprosy	0.000511	0.0041	CcSEcCtD
Lamivudine—Chest pain—Thalidomide—leprosy	0.000511	0.0041	CcSEcCtD
Lamivudine—Anxiety—Thalidomide—leprosy	0.00051	0.00409	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000508	0.00408	CcSEcCtD
Lamivudine—Discomfort—Thalidomide—leprosy	0.000505	0.00405	CcSEcCtD
Lamivudine—Dry mouth—Thalidomide—leprosy	0.0005	0.00401	CcSEcCtD
Lamivudine—Confusional state—Thalidomide—leprosy	0.000494	0.00397	CcSEcCtD
Lamivudine—Oedema—Thalidomide—leprosy	0.00049	0.00393	CcSEcCtD
Lamivudine—Infection—Thalidomide—leprosy	0.000487	0.00391	CcSEcCtD
Lamivudine—Shock—Thalidomide—leprosy	0.000482	0.00387	CcSEcCtD
Lamivudine—Nervous system disorder—Thalidomide—leprosy	0.000481	0.00386	CcSEcCtD
Lamivudine—Thrombocytopenia—Thalidomide—leprosy	0.00048	0.00385	CcSEcCtD
Lamivudine—Skin disorder—Thalidomide—leprosy	0.000476	0.00382	CcSEcCtD
Lamivudine—Hyperhidrosis—Thalidomide—leprosy	0.000474	0.0038	CcSEcCtD
Lamivudine—Anorexia—Thalidomide—leprosy	0.000467	0.00375	CcSEcCtD
Lamivudine—Hypotension—Thalidomide—leprosy	0.000458	0.00368	CcSEcCtD
Lamivudine—ABCG2—testis—leprosy	0.000451	0.00621	CbGeAlD
Lamivudine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000447	0.00358	CcSEcCtD
Lamivudine—Insomnia—Thalidomide—leprosy	0.000443	0.00356	CcSEcCtD
Lamivudine—Paraesthesia—Thalidomide—leprosy	0.00044	0.00353	CcSEcCtD
Lamivudine—Dyspnoea—Thalidomide—leprosy	0.000437	0.00351	CcSEcCtD
Lamivudine—Somnolence—Thalidomide—leprosy	0.000436	0.0035	CcSEcCtD
Lamivudine—Dyspepsia—Thalidomide—leprosy	0.000432	0.00346	CcSEcCtD
Lamivudine—Decreased appetite—Thalidomide—leprosy	0.000426	0.00342	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Thalidomide—leprosy	0.000423	0.0034	CcSEcCtD
Lamivudine—Fatigue—Thalidomide—leprosy	0.000423	0.00339	CcSEcCtD
Lamivudine—Constipation—Thalidomide—leprosy	0.000419	0.00336	CcSEcCtD
Lamivudine—Pain—Thalidomide—leprosy	0.000419	0.00336	CcSEcCtD
Lamivudine—Feeling abnormal—Thalidomide—leprosy	0.000404	0.00324	CcSEcCtD
Lamivudine—Gastrointestinal pain—Thalidomide—leprosy	0.000401	0.00322	CcSEcCtD
Lamivudine—Urticaria—Thalidomide—leprosy	0.000389	0.00313	CcSEcCtD
Lamivudine—Abdominal pain—Thalidomide—leprosy	0.000388	0.00311	CcSEcCtD
Lamivudine—Body temperature increased—Thalidomide—leprosy	0.000388	0.00311	CcSEcCtD
Lamivudine—Hypersensitivity—Thalidomide—leprosy	0.000361	0.0029	CcSEcCtD
Lamivudine—Asthenia—Thalidomide—leprosy	0.000352	0.00282	CcSEcCtD
Lamivudine—Pruritus—Thalidomide—leprosy	0.000347	0.00278	CcSEcCtD
Lamivudine—Diarrhoea—Thalidomide—leprosy	0.000335	0.00269	CcSEcCtD
Lamivudine—Dizziness—Thalidomide—leprosy	0.000324	0.0026	CcSEcCtD
Lamivudine—Vomiting—Thalidomide—leprosy	0.000312	0.0025	CcSEcCtD
Lamivudine—Rash—Thalidomide—leprosy	0.000309	0.00248	CcSEcCtD
Lamivudine—Dermatitis—Thalidomide—leprosy	0.000309	0.00248	CcSEcCtD
Lamivudine—Headache—Thalidomide—leprosy	0.000307	0.00246	CcSEcCtD
Lamivudine—Nausea—Thalidomide—leprosy	0.000291	0.00234	CcSEcCtD
Lamivudine—ABCB1—testis—leprosy	0.000222	0.00306	CbGeAlD
Lamivudine—ABCB1—nervous system—leprosy	0.000218	0.00301	CbGeAlD
